Recro Pharma, Inc.·4

Jan 22, 5:02 PM ET

Myers Diane 4

4 · Recro Pharma, Inc. · Filed Jan 22, 2018

Insider Transaction Report

Form 4
Period: 2018-01-18
Myers Diane
Senior VP-Reg./Quality
Transactions
  • Tax Payment

    Common Stock

    2018-01-18$8.89/sh775$6,89018,528 total
  • Exercise/Conversion

    Common Stock

    2018-01-18+2,50019,303 total
  • Exercise/Conversion

    Restricted Stock Units

    2018-01-182,5007,500 total
    Common Stock (2,500 underlying)
Footnotes (2)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]On January 18, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT